Healthcare -
Biotechnology - NASDAQ - US
$ 15.12
1.96 %
$ 614 M
Market Cap
-88.88
P/E
KROS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KROS - Keros Therapeutics, Inc.
392 M
LAST VALUE
80.47%
2 YEAR CAGR
675.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR